Market Overview

Veracyte to Present at the Canaccord Genuity 38th Annual Growth Conference


(NASDAQ:VCYT) today announced that Bonnie H. Anderson,
chairman and chief executive officer, will present at the Canaccord
Genuity 38th Annual Growth Conference on Thursday, August 9, 2018 at
11:30 a.m. Eastern Time in Boston.

The live webcast of the presentation and a subsequent replay may be
accessed by visiting Veracyte's website at
The replay of the webcast will be available shortly after the conclusion
of the presentation and archived on the company's website for 90 days
following the presentation.

About Veracyte

Veracyte (NASDAQ:VCYT) is a leading genomic diagnostics company that is
providing trustworthy and actionable answers that fundamentally improve
patient care when current diagnostic tests are uncertain. The company's
products uniquely combine genomic technology, clinical science and
machine learning to provide answers that give physicians and patients a
clear path forward without risky, costly surgery that is often
unnecessary. Since its founding in 2008, Veracyte has commercialized
three genomic tests, which are transforming the diagnosis of thyroid
cancer, lung cancer and idiopathic pulmonary fibrosis and collectively
target a $2 billion market opportunity. Veracyte is based in South San
Francisco, California. For more information, please visit
and follow the company on Twitter (@veracyte).

Veracyte, Afirma, Percepta, Envisia, the Veracyte logo, and the Afirma
logo are trademarks of Veracyte, Inc.

View Comments and Join the Discussion!